WILSON JAMES N
SEC Form 4 insider trading activity
WILSON JAMES N has filed 12 SEC Form 4 filings (29 transaction rows) across 1 company, with disclosures dating back to 2025. 12 of those filings fall inside the rolling window. Most recent filing: Oct 16, 2026.
On the most recent filing, WILSON JAMES N is listed as Director at CORCEPT THERAPEUTICS INC. Inside the rolling window, WILSON JAMES N reported no open-market purchases and 5 open-market sales totaling $5.1M in CORT. The largest disclosed transaction in the window is a sale of 10,000 CORT shares on Oct 15, 2026, worth $1.1M.
Companies traded
Other insiders at CORT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has WILSON JAMES N made?
WILSON JAMES N has filed 12 SEC Form 4 filings (29 transaction rows) across 1 company since 2025.
Which companies does WILSON JAMES N trade?
WILSON JAMES N has filed SEC Form 4 disclosures for 1 company, including CORT.
When was WILSON JAMES N's most recent SEC Form 4 filing?
WILSON JAMES N's most recent SEC Form 4 filing on Tracefour is dated Oct 16, 2026.
What is WILSON JAMES N's total buy and sell value in the current window?
Inside the rolling retention window, WILSON JAMES N bought $0 and sold $5.1M based on SEC Form 4 filings.
What was WILSON JAMES N's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 CORT shares on 2026-10-15, worth $1.1M, per SEC Form 4 filings.